KR830000208A - Process for preparing thienyl-prostaglandins - Google Patents

Process for preparing thienyl-prostaglandins Download PDF

Info

Publication number
KR830000208A
KR830000208A KR7600522A KR760000522A KR830000208A KR 830000208 A KR830000208 A KR 830000208A KR 7600522 A KR7600522 A KR 7600522A KR 760000522 A KR760000522 A KR 760000522A KR 830000208 A KR830000208 A KR 830000208A
Authority
KR
South Korea
Prior art keywords
hydrogen
group
hydroxy
alkyl
structural formula
Prior art date
Application number
KR7600522A
Other languages
Korean (ko)
Other versions
KR830000208B1 (en
Inventor
채드윅크 머독크 키이쓰
에밀 더어 푸레드릭
그랏싱 차일드 랄프
Original Assignee
죤 제이 헤이간
아메리칸 사이아나밋드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 죤 제이 헤이간, 아메리칸 사이아나밋드 캄파니 filed Critical 죤 제이 헤이간
Priority to KR1019760000522A priority Critical patent/KR830000208B1/en
Application granted granted Critical
Publication of KR830000208B1 publication Critical patent/KR830000208B1/en
Publication of KR830000208A publication Critical patent/KR830000208A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Title compds. I(R1,R2 = H, OH; R3 = α- or β-thienyl, α- or β-thienylmethyl, benzo[b thiophene, cyclopentano[b thiopene, cyclohexano[b thiopene; X = C1-7 straight-or sidechain alkylene, C2-8 alkoxyalkylene), exhibiting a hypotension activity and a urination activity, were prepd. by the reaction of lactol (II) and 4-carboxy-butyl-triphenylphosphonium bromide in NaH-dissolved dimethylsulfoxide in the presence of inert gas to give formula acid(II), which was acid hydrolyzed to give compds. I or their esters by eliminating tetrahydropyranyl protecting group.

Description

신규한 안트라퀴논 유도체의 제조방법Method for preparing novel anthraquinone derivatives

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (1)

다음 구조식(II) 화합물을 다음 구조식(III) 화합물과 반응시키고 필요에 따라 CH2-CH2인 A-B를 CH=CH로 전환시켜 다음 구조식(I) 화합물을 그 호변이성체와 약물로 사용 가능한 그의 산부가염을 제조하는 방법.The following structural formula (I) is reacted with the following structural formula (III) and, if necessary, converts AB, which is CH 2 -CH 2 , to CH = CH, to give the following structural formula (I) compounds as tautomers and drugs thereof. How to prepare salt. 상기(I)식에서 A-B는 CH=CH 또는 CH2-CH2이고,In formula (I), AB is CH = CH or CH 2 -CH 2 , 에서 선택된 2가의 분자단이며(여기서 n은 2~4의 정수이다)Is a divalent molecular group selected from where n is an integer from 2 to 4 R1과 R2는 각각 수소 C1~C4의 알킬, 질소원자에 대해 α위치에 있는 탄소원자에 하이드록시기를 갖지 않을 수 있는 C2~C4의 모노하이드록시알킬, 질소원자에 대해 α위치에 있는 탄소원자에는 하이드록시기를 갖지 않을 수 있는 C3~C6의 디하이드록시알킬, 포르밀, C2~C4의 알카노일, 트리플루오로아세틸 또는 구조식의 기이며, 여기서 n은 2~4의 정수이고 R은 C1~C4의 알킬, R3와 R4는 각각 수소, C1~C4의 알킬, 질소원자에 대해 α위치에 있는 탄소원자에 하이드록시기를 갖을 수 있는 C2~C4의 모노하이드록시알킬이다.R 1 and R 2, each independently, are hydrogen C 1 ~ C 4 alkyl, C 2 ~ which may not have a hydroxy group at a carbon atom in the α position relative to the nitrogen atom to C 4 mono-hydroxy about hydroxyalkyl, a nitrogen atom α of Carbon atoms at position C 3 to C 6 dihydroxyalkyl, formyl, C 2 to C 4 alkanoyl, trifluoroacetyl or structural formula which may not have a hydroxy group Where n is an integer from 2 to 4 and R is an alkyl of C 1 to C 4 , R 3 and R 4 are each hydrogen, an alkyl of C 1 to C 4 , a carbon atom at the α position with respect to a nitrogen atom C 2 to C 4 monohydroxyalkyl which may have a hydroxy group. R1과 R2는 인접한 질소원자와 함께 또는 R3와 R4는 인접한 질소원자와 함께 모르폴리노, 티오모르폴리노, 피페라지노, 4-메틸-1-피페라지노 또는 구조식-N(CH2)m의 기일 수 있다. 여기서 m은 총탄소수와 1 및 4위치의 측쇄에 있는 총질소원자수와 산소원자수의 합과의 비가 4를 넘지 않는다면 2~6의 정수이다.R 1 and R 2 together with the adjacent nitrogen atom or R 3 and R 4 together with the adjacent nitrogen atom are morpholino, thiomorpholino, piperazino, 4-methyl-1-piperazino or structural formula-N ( CH 2 ) m may be a group. Where m is an integer from 2 to 6 unless the ratio of the total carbon number to the sum of the total number of nitrogen atoms and the number of oxygen atoms in the side chains at positions 1 and 4 does not exceed 4. R5는 수소, 하이드록시, 클로로 또는 C1~C6의 알카노일옥시기이고,R 5 is hydrogen, hydroxy, chloro or alkanoyloxy group of C 1 to C 6 , R6는 수소 또는 하이드록시이고,R 6 is hydrogen or hydroxy, R7은 수소, 하이드록시, 클로로, C1~C6의 알카노일옥시, 또는 구조식의 기이다. 여기서 R8과 R9는 각각 메틸, 에틸 또는 β-하이드록시 에틸기이다.R 7 is hydrogen, hydroxy, chloro, C 1 to C 6 alkanoyloxy, or a structural formula It is the flag of. Wherein R 8 and R 9 are each methyl, ethyl or β-hydroxy ethyl groups. Q가 -(CH2)n-일때는When Q is-(CH 2 ) n- a) R1,R2,R5,R6및 R7은 동시에 수소일 수 없고,a) R 1 , R 2 , R 5 , R 6 and R 7 may not be hydrogen at the same time, b) R5,R6및 R7이 수소일때는 R1/R2는 H/모노 하이드록시알킬일 수 없고;b) R 1 / R 2 cannot be H / mono hydroxyalkyl when R 5 , R 6 and R 7 are hydrogen; n이 2일때는 R1/R2는 -(CH2)2-O-(CH2)-, H/CH3H/C2H5또는 C2H5/C2H5일 수 없고,when n is 2, R 1 / R 2 may not be-(CH 2 ) 2 -O- (CH 2 )-, H / CH 3 H / C 2 H 5 or C 2 H 5 / C 2 H 5 , n이 3일때는 R1/R2는 CH3/CH3또는 -(CH2)5-일 수 없다.When n is 3, R 1 / R 2 may not be CH 3 / CH 3 or-(CH 2 ) 5- . c) R5와 R7이 하이드록시 일때;c) when R 5 and R 7 are hydroxy; n이 2이면 R1/R2는 CH3/CH3ㆍC4H9/C4H9또는 -(CH2)5-일 수 없고,when n is 2, R 1 / R 2 may not be CH 3 / CH 3 ㆍ C 4 H 9 / C 4 H 9 or-(CH 2 ) 5-, n이 3이면 R1/R2는 H/H ㆍCH3/CH3ㆍC3H7/C3H7또는 -(CH2)2-O-(CH2)2-일 수 없고,When n is 3 R 1 / R 2 are H / H and CH 3 / CH 3 and C 3 H 7 / C 3 H 7 or - (CH 2) 2 -O- ( CH 2) 2 - can not work, n이 4이면 R1/R2는 C2H5/C2H5, C4H9/C4H9, 또는 -(CH2)4-일 수 없고,when n is 4 R 1 / R 2 may not be C 2 H 5 / C 2 H 5 , C 4 H 9 / C 4 H 9 , or-(CH 2 ) 4- , d) R5가 OH일때는 R6와 R7중의 하나는 수소이어야 하고 R5가 수소일 때는 R6와 R7둘다 수소이어야 한다.d) R 5 is OH when R 6 is and R 7 is not to be one of R 6 and R 7 both hydrogen when the hydrogen and that R 5 be hydrogen. 구조식(II)와 (III)에서In structural formulas (II) and (III) X와 Y중 하나는 NR1R2또는 NHCOCF3이고 나머지 하나는 OR10, Cl, Br, I, N(R10)2, NO2, SO3R10, SO2R10, SR10, N3, ONO 또는 테트라클릴기이다. 여기서 R10은 수소, C1~C6의 알킬, 페닐, 파라-톨릴 또는 벤진기이다. S와 T는 서로 다르고 0 또는 1이다.One of X and Y is NR 1 R 2 or NHCOCF 3 and the other is OR 10 , Cl, Br, I, N (R 10 ) 2 , NO 2 , SO 3 R 10 , SO 2 R 10 , SR 10 , N 3 , ONO or a tetracyclyl group. Wherein R 10 is hydrogen, C 1 -C 6 alkyl, phenyl, para-tolyl or benzine group. S and T are different from each other and are zero or one. Z는 수소, C1~C4의 알킬 또는 NR1R2나 이렇게 전환될 수 있는 기이다.Z is hydrogen, C 1 -C 4 alkyl or NR 1 R 2 or a group so convertible. 다만;but; a) X만이 NHCOCF3일 수 있고 S가 0일 때만이 Z는 수소 또는 알킬이 아니다.a) Only X can be NHCOCF 3 and only when S is 0 Z is not hydrogen or alkyl. b) a)와 같은 예외로서, S가 0일때는 R1/R2는 H/H이고 Z는 수소나 C1~C4의 알킬이 아니다.b) With the same exception as a), when S is 0, R 1 / R 2 is H / H and Z is not hydrogen or C 1 -C 4 alkyl. c) T가 0이고 Y가 NR1R2일때는 Z는 수소이다.c) When T is 0 and Y is NR 1 R 2 , Z is hydrogen. d) T가 0이고 X가 NR1R2일때는 R1과 R2중 최소한 하나는 수소이고 C1~C4의 알킬이다.d) and T is 0 X is NR 1 R 2 is when at least one of R 1 and R 2 is hydrogen alkyl of C 1 ~ C 4. e) R5와 R7중의 하나가 염소 또는 알카노일옥시기일 때는 다른 것은 같고 R6는 수소이다.e) When one of R 5 and R 7 is a chlorine or alkanoyloxy group, the other is the same and R 6 is hydrogen. f) R1과 R2중 하나만이 알카노일기이고,f) only one of R 1 and R 2 is an alkanoyl group, R5=R7이 클로로 또는 알카노일옥시기일때는 이들은 하이드록시기로 전환시키고, X가 NHCOCF3일때는 COCF3기를 제거시키고, Z가 NR1R2로 전환될 수 있는 기일때는 그렇게 전환시킨다.When R 5 = R 7 is a chloro or alkanoyloxy group they are converted to a hydroxy group, when X is NHCOCF 3 it removes the COCF 3 group and when Z is a group which can be converted to NR 1 R 2 . ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019760000522A 1976-03-04 1976-03-04 Process for preparing thienyl-prostaglandin KR830000208B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019760000522A KR830000208B1 (en) 1976-03-04 1976-03-04 Process for preparing thienyl-prostaglandin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019760000522A KR830000208B1 (en) 1976-03-04 1976-03-04 Process for preparing thienyl-prostaglandin

Publications (2)

Publication Number Publication Date
KR830000208B1 KR830000208B1 (en) 1983-02-23
KR830000208A true KR830000208A (en) 1983-03-30

Family

ID=19202034

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019760000522A KR830000208B1 (en) 1976-03-04 1976-03-04 Process for preparing thienyl-prostaglandin

Country Status (1)

Country Link
KR (1) KR830000208B1 (en)

Also Published As

Publication number Publication date
KR830000208B1 (en) 1983-02-23

Similar Documents

Publication Publication Date Title
ES438431A1 (en) Daunomycin analogues, their preparation and use
ES438303A1 (en) Benzothiophene compounds and the production and use thereof
GB1353542A (en) Polymeric n-carbonyl sulphonamides and a process for their manu facture
ES437994A1 (en) Compounds with ergoline skeleton
ATE26839T1 (en) AMINOPHTACENE DERIVATIVES AND THEIR PRODUCTION.
ES8101622A1 (en) Anthracycline derivatives, a process for their preparation and pharmaceutical compositions containing them.
ES453264A1 (en) Daunorubicin derivatives
KR830000208A (en) Process for preparing thienyl-prostaglandins
IL40088A (en) Tri-iodinated n-methyldicarboxylic acid anilides and process for their manufacture
ES423699A1 (en) 3-oxyiminomethyl-cephalosporins
ES428267A1 (en) 1,2,2A,3,4,5 Hexahydrobenz{8 c,d{9 indol-1-yl-2-guanidines
GB1319890A (en) Substituted nitroalkyl nitrate and pernitrate
ES440723A1 (en) Organic compounds
GB1353536A (en) Antiviral compositions containing bisbasic ethers and thioethers of xanthene and xanthen-9-ones and methods of treating viruses therewith
GB1512236A (en) Thiophene derivatives and process for their manufacture
GB1466411A (en) Sulphur-containing hydroxy aliphatic compounds
ES458932A1 (en) Bicyclomycin derivatives, compositions thereof and process of use thereof
GB1532551A (en) Furo(3,4-6)furone derivatives and their preparation
ES433862A1 (en) Chromium complex dyes their manufacture and use
GB1313228A (en) Tri-iodo-benzoic acid derivatives
ES449961A1 (en) Substituted (alkoxycarbonylthioureido)-(acylamino)-benzene derivatives
ES440962A1 (en) Alkylindene-bisphenols containing sulphur and their use as stabilisers
ES461566A1 (en) Poly(oxyalkylene)-polyester-poly(sulphide)-polythiols and a process for the preparation thereof
ES391263A1 (en) Mixture of quinophthalone dispense dyestuffs
ES427905A1 (en) Process for bulk dyeing high molecular organic compounds